Arkolith/Insider Trading/STOK/Form 4

Harrison Seth Loring

DirectorStoke Therapeutics, Inc. (STOK) · full profile →Form 4 · filed Jul 17, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
16
0 non-derivative · 16 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 16, 2026Gift(G)30K—$00
Jul 16, 2026Gift(G)30K—$030K
Jul 16, 2026Gift(G)15K—$00
Jul 16, 2026Gift(G)15K—$015K
Jul 16, 2026Gift(G)12K—$00
Jul 16, 2026Gift(G)12K—$012K
Jul 16, 2026Gift(G)21K—$00
Jul 16, 2026Gift(G)21K—$021K
Jul 16, 2026Gift(G)19K—$00
Jul 16, 2026Gift(G)19K—$019K
Jul 16, 2026Gift(G)8K—$00
Jul 16, 2026Gift(G)8K—$08K
Jul 16, 2026Gift(G)30K—$00
Jul 16, 2026Gift(G)30K—$030K
Jul 16, 2026Gift(G)18K—$00
Jul 16, 2026Gift(G)18K—$018K

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001404955-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML